Clinical Trial Update: Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pembrolizumab with combination chemotherapy in untreated diffuse large B-cell lymphoma and grade 3b follicular lymphoma with completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: University of Washington | Conditions: Composite Lymphoma, Grade 3b Follicular Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2020-09-23